Kill that pain

One of Israel’s NASDAQ listed bio-techs BiolineRX Ltd. reported positive results for its Phase Ia clinical trial of its drug, BL-1021, for the treatment of chronic neuropathic pain due to damaged nerves. It is associated with conditions including shingles, diabetes and cancer, affecting 1-3% of the world’s population.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.